Bright Minds Biosciences' BMB-101, a 5-HT2C receptor agonist, shows promise in treating drug-resistant epilepsy, with favorable Phase 1 safety and efficacy data. The company's proprietary platform ...

HOUSTON, Dec. 4, 2025 /PRNewswire/ -- Bowen, Miclette & Britt Insurance Agency, LLC has continued the expansion of its Surety team with the addition of John Anthony Martinez, who brings nearly 20 ...

Company's BMB-101 targets drug-resistant epilepsy, aiming for a multibillion-dollar market by treating patients unresponsive to standard anti-seizure medications. Company's phase 2 trial for Absence ...

A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Want to share your experience with this dealership? If you are looking for a used Honda, there?s only ...

BTIG initiated coverage on Bright Minds Biosciences Inc. (NASDAQ:DRUG), a clinical-stage company focused on neurological and psychiatric disorders. Investment in Bright Minds is based on the ...

While many of the larger machinery makers at K 2019 are feeling the effects of uncertainty in the global economy — primarily driven by trade conflicts and a global slowdown in automotive — Italian ...

BMB Group is one of the world’s most exclusive financial institutions. Its growing numbers of investors are often drawn from eastern ruling families with vast riches gleaned from the long-term growth ...

BMB-Spa will unveil its "true” hybrid electric injection molding machine to the U.S. market at NPE2012 (booth #323). BMB will be running a 550-ton high-speed manufacturing cell, producing an ultra ...

David Bain, Founding Partner/ CSO/Chair at BMB London, has announced his departure after a long stint of 19 years. Bain took to LinkedIn and said, “I’m out. I’m about. A free-range strategy Herbert.